Paper · 31300673
Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
Carlström KE and 16 others. Nat Commun, 2019. Cited by 118 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Papers, record 31300673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31300673
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dimethyl Fumarate | Major topic |
| Immunosuppressive Agents | Major topic |
| Monocytes | Major topic |
| Multiple Sclerosis, Relapsing-Remitting | Major topic |
| NADPH Oxidases | Major topic |
| Adult | |
| DNA Methylation | |
| Epigenesis, Genetic | |
| Female | |
| Humans | |
| Leukocyte Count | |
| Longitudinal Studies | |
| Male | |
| Middle Aged | |
| NF-E2-Related Factor 2 | |
| Polymorphism, Single Nucleotide | |
| Prospective Studies | |
| Reactive Oxygen Species | |
| T-Lymphocytes | |
| Treatment Outcome |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05112484 | Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,992,073 | Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22992073 | PubMed |
| 2 | 16,814,112 | NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. | Free Radic Biol Med | 2006 | https://conductscience.org/library/papers/16814112 | PubMed |
| 3 | 24,336,642 | ChAMP: 450k Chip Analysis Methylation Pipeline. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24336642 | PubMed |
| 4 | 14,567,559 | Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta. | Autoimmunity | 2003 | https://conductscience.org/library/papers/14567559 | PubMed |
| 5 | 26,767,188 | Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2016 | https://conductscience.org/library/papers/26767188 | PubMed |
| 6 | 29,928,650 | The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. | Ann Clin Transl Neurol | 2018 | https://conductscience.org/library/papers/29928650 | PubMed |
| 7 | 27,687,891 | Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases. | Clin Rev Allergy Immunol | 2017 | https://conductscience.org/library/papers/27687891 | PubMed |
| 8 | 21,848,345 | Isoprostane generation and function. | Chem Rev | 2011 | https://conductscience.org/library/papers/21848345 | PubMed |
| 9 | 25,738,172 | Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate. | Neurol Neuroimmunol Neuroinflamm | 2015 | https://conductscience.org/library/papers/25738172 | PubMed |
| 10 | 22,257,669 | The sva package for removing batch effects and other unwanted variation in high-throughput experiments. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22257669 | PubMed |
1 to 10 of 67
See all 67 referencesCited by82
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,957,749 | Transcription factor EB as a novel target for dimethyl fumarate to restore endothelial function in diabetes. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42957749 | PubMed |
| 42,593,635 | Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions. | Neurol Ther | 2026 | https://conductscience.org/library/papers/42593635 | PubMed |
| 42,047,854 | The hypoxia-inflammation cycle as a key mechanism of smoldering inflammation and progression in multiple sclerosis. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42047854 | PubMed |
| 41,881,983 | Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41881983 | PubMed |
| 41,639,279 | A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/41639279 | PubMed |
| 41,574,701 | MTHFR‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41574701 | PubMed |
| 41,383,596 | Metabolic reprogramming of macrophages in chronic obstructive pulmonary disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41383596 | PubMed |
| 41,339,603 | Nox3 expression and function in retinal ganglion cells and Amacrine cells. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/41339603 | PubMed |
| 41,281,740 | Macrophage Immunometabolism in Pulmonary Homeostasis and Chronic Lung Diseases. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/41281740 | PubMed |
| 40,722,916 | Alzheimer's Disease Pathogenic Mechanisms: Linking Redox Homeostasis and Mitochondria-Associated Metabolic Pathways Through Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2). | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40722916 | PubMed |
1 to 10 of 82
See all 82 cited byGenes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CCL28 | 56,477 | PubTator's text mining | https://conductscience.org/library/genes/56477 | NCBI Gene |
| CCL4 | 6,351 | PubTator's text mining | https://conductscience.org/library/genes/6351 | NCBI Gene |
| CCR2 | 729,230 | PubTator's text mining | https://conductscience.org/library/genes/729230 | NCBI Gene |
| CCR7 | 1,236 | PubTator's text mining | https://conductscience.org/library/genes/1236 | NCBI Gene |
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CDCP1 | 64,866 | PubTator's text mining | https://conductscience.org/library/genes/64866 | NCBI Gene |
| CLCN7 | 1,186 | PubTator's text mining | https://conductscience.org/library/genes/1186 | NCBI Gene |
| CREBBP | 1,387 | PubTator's text mining | https://conductscience.org/library/genes/1387 | NCBI Gene |
1 to 10 of 33
See all 33 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31300673
GET https://conductscience.org/api/papers/v1/31300673/references?page=2